Carlos Abril-Pérez (C Abril-Pérez)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Clinical and experimental dermatology

Dermatologic therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Abril-Pérez, Mansilla-Polo Miguel, Daniel Martin-Torregrosa, Rafael Botella-Estrada
Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment. Clinical and experimental dermatology (2023)
Mansilla-Polo Miguel, Carlos Abril-Pérez, Daniel Martín-Torregrosa, Javier López-Davia, Blanca de Unamuno-Bustos, Ignacio Torres-Navarro, Begoña Escutia-Muñoz, Rafael Botella-Estrada
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice. The Australasian journal of dermatology (2023)
Rodolfo David Palacios-Diaz, Javier Sánchez-Arráez, Carlos Abril-Pérez, Mónica Pozuelo-Ruiz, Ignacio Torres-Navarro, Javier López-Davia, Ana Facal-Malvar, Rafael Botella-Estrada
Foreign body reaction to silicone after hematopoietic stem cell transplantation. International journal of dermatology (2022)
Carlos Abril-Pérez, Rodolfo David Palacios-Diaz, Miguel Ángel Navarro-Mira, Rafael Botella-Estrada
Succesful treatment of erythema nodosum leprosum with apremilast. Dermatologic therapy (2021)
Ignacio Torres-Navarro, Carlos Abril-Pérez, Juncal Roca-Ginés, Javier Sánchez-Arráez, R Botella-Estrada, M Évole-Buselli
Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19. Clinical and experimental dermatology 45 (6) (2020)
Ignacio Torres-Navarro, Carlos Abril-Pérez, Juncal Roca-Ginés, Javier Sánchez-Arráez, R Botella-Estrada
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2020)